Does Cigna Pay for GLP-1 Medications? (2026)

Whether Cigna covers a GLP-1 depends on your specific plan; prior authorization is required, and members who are approved typically pay $25-$75 a month.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Where Cigna stands[1]
Depends on the Plan
18,000,000 members · Prior authorization needed[1]
Depends on the Plan

If your question is only about Wegovy and Zepbound, read does Cigna cover Zepbound and Wegovy, which explains why the Zepbound pen is covered on the Express Scripts list while the KwikPen and vials are not.

Where Each Medication Stands[5]

How Cigna handles each GLP-1, and the usual copay when one is covered. Copay in USD per month.
MedicationWhat Cigna does
Wegovy (semaglutide)Cigna's own weight-loss drug policy says these medications are specifically excluded under many benefit plans, employer groups and individual plans alike, so the plan document comes first. Where Wegovy is covered it needs prior authorization under Cigna's National Formulary Wegovy injection policy (review date 06/17/2026). Adults on the weight indication need to be >=18, to have at least 3 months of behavioral modification and dietary restriction already behind them, and to carry BMI >=30 - or >=27 with one of the weight-related comorbidities Cigna lists: hypertension, dyslipidemia, type 2 diabetes, cardiovascular or coronary artery disease, sleep apnea, knee osteoarthritis, polycystic ovarian syndrome, MASLD/NAFLD, asthma or COPD. The drug has to be taken alongside behavioral changes and a reduced-calorie diet. That buys 8 months. Renewal comes in 1-year blocks and is contingent on documented >=5% loss from baseline body weight. Patients from age 12 have their own pediatric route, also starting at 8 months. A cardiovascular route approves an adult with BMI >=27 and a prior heart attack, stroke or symptomatic PAD for 1 year, used with optimized heart medication, and a MASH route covers fibrosis stage F2-F3 without cirrhosis. On the 2026 Express Scripts National Preferred Formulary, Wegovy pens, Wegovy HD and Wegovy tablets are all on the covered list.
Ozempic (semaglutide)Covered for type 2 diabetes under Cigna's National Formulary GLP-1 diabetes policy (CNF 360, review date 06/03/2026): Ozempic injection and Ozempic tablets are approved for 1 year in patients 18 and over. The policy lists weight loss as a condition not covered, because these products are not FDA-approved for it. The 130-day oral-diabetes-drug lookback in earlier versions of CNF 360 does not appear in the June 2026 text; the plan's own drug list may still apply a step.
Zepbound (tirzepatide)Cigna now publishes a Zepbound-only policy, IP0816 (effective 09/01/2026), and prior authorization is required. The adult weight gate is the same 4-prong test Cigna applies to Wegovy: age >=18, a 3-month behavioral and diet trial, lifestyle treatment alongside the drug, and BMI >=30 - or >=27 carrying one of the listed comorbidities. 8 months on the first approval, then 1-year renewals against >=5% loss from baseline body weight. Sleep apnea is a separate route with a harder renewal than the weight one. Entry needs a sleep study showing AHI (or REI) >=15, a BMI of 30 or more, and the absence of central sleep apnea and of Cheyne-Stokes breathing; the first approval runs 1 year. Keeping it requires >=10% body-weight loss after >=1 year AND stable OSA signs or symptoms per the prescriber. Product form matters on the 2026 Express Scripts National Preferred Formulary: Zepbound single-dose pens are covered, while Zepbound KwikPens and vials are excluded - and those are the forms Lilly sells for cash. Cigna's Zepbound quantity policy (CNF 840) caps fills at 4 pens per 28 days at retail, or 12 per 84 days.
Mounjaro (tirzepatide)Covered for type 2 diabetes under the same CNF 360 policy (review date 06/03/2026), approved for 1 year in patients 10 and over; weight loss is listed as not covered. Mounjaro is on the covered list of the 2026 Express Scripts National Preferred Formulary. The 130-day oral-diabetes-drug lookback in earlier versions of CNF 360 does not appear in the June 2026 text.
Foundayo (orforglipron)Covered with prior authorization per IP0206, which Cigna now publishes as a Foundayo-only policy (effective 09/01/2026), on the same 4-prong adult gate Cigna applies to Wegovy and Zepbound: >=18, a 3-month behavioral and diet trial, BMI >=30 (or >=27 alongside one of the listed weight-related comorbidities), and concomitant lifestyle treatment. The clock: 8 months on the initial approval, then 1 year at a time, each renewal contingent on documented >=5% loss from baseline body weight. Foundayo is on the covered list of the 2026 Express Scripts National Preferred Formulary, and the plan document still decides whether weight-loss drugs are covered at all.
Copay when it is covered$25-$75 / month

What a GLP-1 costs a Cigna member

At Cigna's typical copay of $25-$75 a month, a covered year of a GLP-1 costs $300 to $900. That is $3,288 to $3,888 less than a year of Wegovy bought for cash from NovoCare ($4,188), and Zepbound's LillyDirect price of $299 to $449 a month is further above it still.

The cheapest compounded option, WellMedRx at $49/mo ($588 a year), lands inside the Cigna range, and 3 sellers charge no more than the $75 top of it, so for a member facing that copay a denial costs less than it sounds.

When Cigna covers the drug, a manufacturer savings card can bring a Wegovy or Zepbound fill down to $25, with each maker paying at most $100 a month.

Employers whose plans run through Cigna

Your employer decides much of this. Among the employers in our coverage checker, 2 use Cigna to run medical or pharmacy benefits: Amazon and JPMorgan Chase. Amazon's Wegovy position, for example: Clinically eligible employees and adult dependents may receive GLP-1 medication through the 9amHealth weight management program (since Jan 1, 2026: BMI 35 or higher with two or more qualifying conditions, or BMI 27 or higher with heart disease). 9amHealth does not name which GLP-1 brands are covered; copays/cost-shares may apply. Verify the specific drug with A to Z Benefits or MyHR.

After a Denial from Cigna

A Cigna denial leaves two routes: an appeal, and paying cash. With a prescription, a brand-name GLP-1 is generally an eligible HSA or FSA medical expense[3]. Compounded semaglutide and tirzepatide from licensed 503A pharmacies[4] cost far less than the brand; the cheapest sellers are listed below.

If a large employer self-funds your Cigna plan, ERISA rather than state insurance law applies and the employer decides whether anti-obesity drugs are covered[2]; the Summary Plan Description says which.

Cigna's PA criteria, quoted from the policy PDFs

Every Cigna GLP-1 PA clause is reproduced word for word in our guide: the CNF 840 quantity limits, the Wegovy MACE pathway, the Zepbound OSA pathway, the change making Mounjaro available from ≥10 years old, how Foundayo (orforglipron) is handled, the comorbidity list of 11 conditions, and the step-therapy rule running 130 days that excludes single-entity metformin. Read it in the Cigna GLP-1 Prior Authorization Guide.

Where to go if Cigna says no

The 8 cheapest cash-pay compounded GLP-1s

Cheapest cash-pay compounded GLP-1 sellers
#SellerMonthly priceVisit
1WellMedRx
Compounded semaglutide
$49/moVisit
2Collective
Compounded semaglutide
$59/moVisit
3RenewlyRX
Compounded semaglutide
$68/moReview
4Lean Meds
Compounded semaglutide
$79/moReview
5Tryozi
Compounded semaglutide
$79/moReview
6Embody
Compounded semaglutide
$79/moVisit
7NextMeds
Compounded semaglutide
$79/moReview
8CoreAge Rx
Compounded semaglutide
$79/moVisit

Top-rated sellers that bill insurance

23 sellers say they accept insurance. Confirm with the seller that it bills Cigna before you book.

Sellers that bill insurance
#SellerCash priceVisit
1NovoCare Pharmacy$149/moReview
2Ivim Health$140/moVisit
3Thrivelab$175/moReview
4Spry$199/moReview
5Calibrate HealthPrice not publishedReview

Every seller and price, side by side: compare all sellers.

Our picks

Starting price per provider. Prices in USD per month; checked November 2026.
#ProviderScore
1EmbodyVisit
2CollectiveVisit
3MyDrHankVisit
4YourEraVisit
5EdenVisit

Frequently Asked Questions

Cigna's own weight-loss drug policy says these medications are specifically excluded under many benefit plans, employer groups and individual plans alike, so the plan document comes first. Where Wegovy is covered it needs prior authorization under Cigna's National Formulary Wegovy injection policy (review date 06/17/2026). Adults on the weight indication need to be >=18, to have at least 3 months of behavioral modification and dietary restriction already behind them, and to carry BMI >=30 - or >=27 with one of the weight-related comorbidities Cigna lists: hypertension, dyslipidemia, type 2 diabetes, cardiovascular or coronary artery disease, sleep apnea, knee osteoarthritis, polycystic ovarian syndrome, MASLD/NAFLD, asthma or COPD. The drug has to be taken alongside behavioral changes and a reduced-calorie diet. That buys 8 months. Renewal comes in 1-year blocks and is contingent on documented >=5% loss from baseline body weight. Patients from age 12 have their own pediatric route, also starting at 8 months. A cardiovascular route approves an adult with BMI >=27 and a prior heart attack, stroke or symptomatic PAD for 1 year, used with optimized heart medication, and a MASH route covers fibrosis stage F2-F3 without cirrhosis. On the 2026 Express Scripts National Preferred Formulary, Wegovy pens, Wegovy HD and Wegovy tablets are all on the covered list.
Covered for type 2 diabetes under Cigna's National Formulary GLP-1 diabetes policy (CNF 360, review date 06/03/2026): Ozempic injection and Ozempic tablets are approved for 1 year in patients 18 and over. The policy lists weight loss as a condition not covered, because these products are not FDA-approved for it. The 130-day oral-diabetes-drug lookback in earlier versions of CNF 360 does not appear in the June 2026 text; the plan's own drug list may still apply a step.
Cigna now publishes a Zepbound-only policy, IP0816 (effective 09/01/2026), and prior authorization is required. The adult weight gate is the same 4-prong test Cigna applies to Wegovy: age >=18, a 3-month behavioral and diet trial, lifestyle treatment alongside the drug, and BMI >=30 - or >=27 carrying one of the listed comorbidities. 8 months on the first approval, then 1-year renewals against >=5% loss from baseline body weight. Sleep apnea is a separate route with a harder renewal than the weight one. Entry needs a sleep study showing AHI (or REI) >=15, a BMI of 30 or more, and the absence of central sleep apnea and of Cheyne-Stokes breathing; the first approval runs 1 year. Keeping it requires >=10% body-weight loss after >=1 year AND stable OSA signs or symptoms per the prescriber. Product form matters on the 2026 Express Scripts National Preferred Formulary: Zepbound single-dose pens are covered, while Zepbound KwikPens and vials are excluded - and those are the forms Lilly sells for cash. Cigna's Zepbound quantity policy (CNF 840) caps fills at 4 pens per 28 days at retail, or 12 per 84 days.
Covered for type 2 diabetes under the same CNF 360 policy (review date 06/03/2026), approved for 1 year in patients 10 and over; weight loss is listed as not covered. Mounjaro is on the covered list of the 2026 Express Scripts National Preferred Formulary. The 130-day oral-diabetes-drug lookback in earlier versions of CNF 360 does not appear in the June 2026 text.
Covered with prior authorization per IP0206, which Cigna now publishes as a Foundayo-only policy (effective 09/01/2026), on the same 4-prong adult gate Cigna applies to Wegovy and Zepbound: >=18, a 3-month behavioral and diet trial, BMI >=30 (or >=27 alongside one of the listed weight-related comorbidities), and concomitant lifestyle treatment. The clock: 8 months on the initial approval, then 1 year at a time, each renewal contingent on documented >=5% loss from baseline body weight. Foundayo is on the covered list of the 2026 Express Scripts National Preferred Formulary, and the plan document still decides whether weight-loss drugs are covered at all.
Members who are approved typically pay $25-$75 a month, which is $300 to $900 over a year. A manufacturer savings card can lower that further when the plan covers the drug.
Appeal first: ask Cigna for the written denial and the criteria it applied, and have your prescriber answer them in a letter of medical necessity. If the appeal fails, the cheapest cash route is compounded semaglutide or tirzepatide, from WellMedRx at $49/mo or Collective at $59/mo. 23 sellers say they bill insurance. A compounded drug is not FDA-approved as a finished product.

Glossary

The words sellers use, defined. Tap any term.

Sources & methodology — as of November 2026
  1. 1.KFF — Employer Health Benefits Annual Survey— Kaiser Family Foundation.
  2. 2.U.S. Department of Labor — ERISA and Employer Health Plans— U.S. Department of Labor, Employee Benefits Security Administration.
  3. 3.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.
  4. 4.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  5. 5.GLP Watchdog insurer coverage index (manually curated formulary data)— GLP Watchdog.